• ALXO

Alx Oncology shares down in pre-market as Jefferies downgrades stock to 'hold'

Alx Oncology's stock was downgraded by Jefferies due to weak clinical trial results and financial constraints, raising concerns over the company's future drug efficacy and pipeline.